1. HIPPOCAMPUS 00:000–000 (2010)RAPID COMMUNICATIONLayer-Specific Alterations to CA1 Dendritic Spines in aMouse Model of Alzheimer’s DiseaseP. Merino-Serrais,1 S. Knafo,1,2*…

1. Ertek, G., Tokdil, B., Günaydın, İ. “Risk Factors and Identifiers for Alzheimer’s Disease: A Data Mining Analysis”. In Proceedings of Industrial Conference on…

1. By Christy Griffith By Christy Griffith 2. Organizational Structure  Sierra View Homes is a not-for-profit community founded by the First Mennonite Church in Reedley,…

1. 48th ACM Southeast Conference. ACMSE 2010.Oxford, Mississippi. April 15-17, 2010.Semantic Predications for Complex Information Needs in Biomedical LiteratureDelroy Cameron,…

1. Cerebral Cortex March 2009;19:586--592doi:10.1093/cercor/bhn111Advance Access publication July 16, 2008Widespread Changes in Dendritic SpinesS. Knafo1, L. Alonso-Nanclares1,…

1. Termination of a Phase 3 Trial of Semagacestat for the Treatment of Alzheimer's Disease Rod Bugawan November 14, 2013 Lipscomb University College of Pharmacy 2. Learning…

627 Historically, policy makers and researchers have used mortality statistics as the principal measure of the seriousness of diseases, based on which countries and organizations…

ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT Presented by: Fariha Fatima JR-1 Department of Pharmacology INTRODUCTION:…

ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT Presented by: Fariha Fatima JR-1 Department of Pharmacology INTRODUCTION:…

Estrogen Receptor mRNA Expression Levels in Brain Tissue of Alzheimer’s Disease Model Mice How ApoE4 Interacts with Estrogen to Cause Alzheimer’s Disease Presenter: Nicholas…